Literature DB >> 25197925

Letters to the Editor: Assessing the cost-effectiveness of allergen immunotherapy in allergic rhinitis.

Cristoforo Incorvaia1, Eleni Makrì, Erminia Ridolo.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25197925      PMCID： PMC5517774          DOI： 10.2500/ajra.2014.28.4068

Source DB:  PubMed          Journal:  Am J Rhinol Allergy        ISSN： 1945-8932            Impact factor:   2.467


× No keyword cloud information.
  5 in total

Review 1.  Economic studies of immunotherapy: a review.

Authors:  Patrizia Berto; Franco Frati; Cristoforo Incorvaia
Journal:  Curr Opin Allergy Clin Immunol       Date:  2008-12

Review 2.  Adult and pediatric clinical trials of sublingual immunotherapy in the USA.

Authors:  Dai Park; Nora Daher; Michael S Blaiss
Journal:  Expert Rev Clin Immunol       Date:  2012-08       Impact factor: 4.473

3.  Decision-making analysis for allergen immunotherapy versus nasal steroids in the treatment of nasal steroid-responsive allergic rhinitis.

Authors:  Joshua L Kennedy; Derek Robinson; Jared Christophel; Larry Borish; Spencer Payne
Journal:  Am J Rhinol Allergy       Date:  2014 Jan-Feb       Impact factor: 2.467

4.  Economic evaluation of sublingual vs subcutaneous allergen immunotherapy.

Authors:  Jitka Pokladnikova; Irena Krcmova; Jiri Vlcek
Journal:  Ann Allergy Asthma Immunol       Date:  2008-05       Impact factor: 6.347

5.  Budget impact analysis of two immunotherapy products for treatment of grass pollen-induced allergic rhinoconjunctivitis.

Authors:  Steen M Rønborg; Ulrik G Svendsen; Jesper S Micheelsen; Lars Ytte; Jakob N Andreasen; Lars Ehlers
Journal:  Clinicoecon Outcomes Res       Date:  2012-09-11
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.